presently show that AD-1, a specific monoclonal antibody originally produced against MemliALP, reacts with physical, morphological, histochemical, and immuno-LAP, a constituent of the human liver plasma mem-logical evidence. Shedding of hepatocyte plasma membrane. Using AD-1 as an immunosorbant, we isolated cir-branes is thought to be involved in the release of memculating LiPMF from cholestatic sera to a high level of brane-bound liver alkaline phosphate (Mem-LiALP) purity and separated it from other high-molecular-mass into the circulation. 3 Because of its structural characmaterial, such as liver ALP Ç lipoprotein-X complexes. teristics, high molecular mass liver ALP was recently These purified membrane fragments retained their bio-renamed Mem-LiALP. 4 Several studies using different chemical characteristics. Glycosyl-phosphatidylinositol supporting media during electrophoresis, such as agar, anchor bearing liver ALP (Anch-LiALP) could be reagarose, starch, polyacrylamide gel, and cellulose ace- 5,6 Beglycosyl-phosphatidylinositol anchor following deter-cause of its sensitivity and specificity, Mem-LiALP has gent solubilization of the enzyme. Serum LiPMF from been advanced as a serum marker of hepatic metastapatients with different kinds of cholestatic liver disease sis. 4,7,8 were bound onto AD-1 coated nitrocellulose disks and Several other membrane-bound enzymes, such as gthe activity of four membrane-bound enzymes (LAP, glutamyltransferase (g-GT), leucine aminopeptidase ALP, 5Nu, g-GT) was analyzed. A considerable interindi-(LAP), and 5-nucleotidase (5-Nu) are present in the vidual variation of enzyme activities was observed, sug-membrane of the shedded vesicles. Both ALP and 5-Nu are attached to the plasma membrane by means of a glycosyl-phosphatidylinositol anchor (GPI-anchor), Abbreviations: ALP, alkaline phosphatase; LiPMF, liver plasma membrane and can be released in vitro by the action of GPI-specific fragments; MemLiALP, membrane-bound liver alkaline phosphate; g-GT, gglutamyltransferase; LAP, leucine aminopeptidase; 5-Nu, 5-nucleotidase; phospholipase-C (GPI-PLC).9,10 The precise mechanism GPI, glycosyl-phosphatidylinositol; GPI-PLC, GPI-specific phospholipase-C;of the in vivo release of these enzymes and the role of (GPI-PLD), abundantly present in serum, might be re- Received December 30, 1994; accepted October 3, 1995. sponsible for the in vivo release of GPI-anchored proSupported by grants from the Sportvereniging tegen Kanker and the Vereteins.11 Shedded plasma membrane vesicles are easily niging voor Kankerbestrijding, Brussels, Belgium.